Exploring innovative solutions to improve the healthcare of the aging and diseased population is still considered as a global challenge. Among a number of strategies to achieve this goal, tissue engineering and regenerative medicine has gradually evolved into a promising approach to meet future needs of patients.
tissue engineering combines cells, scaffolds, and growth factors to regenerate tissues or damaged organs. Today, with the aging of world population, there is a rapid increase in musculoskeletal pathologies such as fractures, low back pain, scoliosis, osteoporosis, bone infection or tumors, congenital defects and oral and maxillofacial pathologies, as well as rheumatic diseases like osteoarthritis. Therefore, the development of bone-related medical treatments and the reduction of costs have attracted the attention of many researchers around the world.
Roseti, L., Parisi, V., Petretta, M., Cavallo, C., Desando, G., Bartolotti, I., & Grigolo, B. (2017). Scaffolds for bone tissue engineering: state of the art and new perspectives. Materials Science and Engineering: C, 78, 1246-1262.
Koons, G. L., Diba, M., & Mikos, A. G. (2020). Materials design for bone-tissue engineering. Nature Reviews Materials, 5(8), 584-603.
Amini, A. R., Laurencin, C. T., & Nukavarapu, S. P. (2012). Bone tissue engineering: recent advances and challenges. Critical Reviews™ in Biomedical Engineering, 40(5).
Matassi, F., Nistri, L., Paez, D. C., & Innocenti, M. (2011). New biomaterials for bone regeneration. Clinical cases in mineral and bone metabolism, 8(1), 21.
OmidAfarinan Baft Ayandeh is a medical technology company focused on regenerative implants produced by additive manufacturing that support the growth of natural tissue and get absorbed over time.
بزرگراه آزادگان، مسير شمال به جنوب، احمدآباد مستوفی، بعد از ميدان پارسا، انتهای خيابان انقلاب، سازمان پژوهشهای علمی و صنعتی ایران. شرکت امیدآفرینان بافت آینده
tel-Fax: (+98)21-66550571
info@asbone.com